Devana Solutions Welcomes Deb Bawcom as Executive Vice President, Program Management

Devana Solutions is pleased to welcome Deb Bawcom as Executive Vice President, Program Management.

Deb is an accomplished, client-focused software executive with a proven track record of creating high-performing teams from the bottom up with a strong productive culture. She brings years of experience managing end-to-end product and program lifecycles, from innovation to design and delivery, through growth and scale-up phases. Deb has a reputation for successfully guiding challenging change initiatives and for building trusting, lasting connections with customers and colleagues.

Deb joins Devana Solutions with over 25 years of experience in project and risk management in the software, construction, and energy commodities industries. As Executive Vice President, Program Management, Deb will oversee Devana’s product strategy and development, managing product lifecycles and mapping out new features and projects. She will also lead our Product and Solutions Services teams, providing guidance and helping us retain top talent.

“Deb Bawcom’s depth of knowledge in Product Development strategy and, most importantly, execution is a perfect fit for the growth stage Devana Solutions has reached very quickly,” commented Barry Lake, Devana Solutions CEO. “Deb’s skills are going to be critical as we remain on the leading edge of clinical trials industry SaaS innovation.”

Devana Solutions is excited to have Deb join our growing team! With her experience and leadership, we plan to take our product strategy to the next level.

Navigating the Great Resignation Within the Clinical Trial Industry

According to the U.S. Department of Labor, a record 4.5 million workers quit their jobs in March 2022—a trend that has continued through the summer. Paired with rising inflation costs, this so-called “Great Resignation” is straining the clinical trial industry like never before. Turnover for both patient-facing and operations staff has been on the rise, causing some trials to come to a screeching halt.  

Clinical trial software such as Devana Solutions PROPEL can help central research operations save time and money by improving workflows and streamlining pipeline management.  

Streamline Processes with Clinical Trial Software 

With high turnover comes frequent regulatory and staff updates, including updating logs, gathering new signatures, and amending databases. Designed specifically for the clinical trial industry, PROPEL provides technological support for various backend workflows, including data entry, reporting, admin support, enrollment, query resolutions, and communications. Say goodbye to duplicate data entry! 

PROPEL enables users to automate tasks and reminders to expedite study start-up and ensure that nothing is overlooked or forgotten as staffing situations change. Teams can also link multiple contacts, documents, and communications across each clinical trial to save time and improve performance visibility. For end-to-end operational excellence, PROPEL integrates with other mission-critical systems, such as your CTMS and Microsoft Outlook. Instead of hunting for lost communications caused by staff turnover, PROPEL creates threaded conversations and allows users to attach documents, link related calls, and even send emails and messages directly from within the platform. 

Utilizing PROPEL, operations professionals can query site capabilities based on therapeutic expertise, investigator and staff certifications, physical site facilities, and more. This enables teams to efficiently share protocols digitally and distribute trial opportunities and documentation to study teams without the need for external communications or cumbersome old databases, saving both time and money. In addition, PROPEL is entirely cloud-based, which makes it simple for remote and decentralized users to log in and execute. 

Specifically designed for efficiency, PROPEL enables teams impacted by turnover and decreased budgets to accomplish more with less. 

Devana Solutions 

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems. 

Let us show you in more detail what Better Data, Better Decisions, and Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs. 

Effectively Manage Decentralized Sites with Clinical Trial Software

Since the beginning of the COVID-19 pandemic, more and more organizations have been exploring the possibilities of decentralized clinical trials (DCTs). Decentralized trials have many benefits, including accelerated patient access, improved patient engagement and retention, and increased diversity. Unfortunately, these benefits also come with challenges such as reduced collaboration and limited data access.

Clinical trial software such as Devana Solutions PROPEL can help central research operations connect to decentralized site staff during study startup through trial completion, regardless of site location.

Increase Collaboration, Data-Sharing, and Visibility Across DCTs

Devana Solution’s cloud-based software seamlessly and securely connects central research sites, CROs, Sponsors, and decentralized sites, facilitating real-time collaboration and sharing of data. Our solutions allow research operations professionals to share protocols, contracts, budgets, and other supporting trial documentation with decentralized sites, speeding study startup and improving visibility across the trial’s network.

Forget managing cumbersome emails, phone calls, and lengthy meetings—central teams can communicate directly to sites within PROPEL, and all correspondence is logged for future reference. Sites can also update their key milestones via our LYNK interface, ensuring the central team is always aware of the status of the trial. Central research teams can even assign tasks to sites and view what has been completed and remains outstanding.

Instead of manually searching for opportunities or site-specific details, PROPEL allows users to query all sites, filter key data, and collate opportunities. Customizable dashboards and reports provide real-time visibility and help centralized and site-based decision-makers gain actionable insights. The Devana Solutions platform can connect every functional group in a network’s entire organization, from business development and regulatory to finance and leadership.

By leveraging the cloud to connect central teams with site-based clinicians and staff for real-time collaboration, PROPEL provides easy access and visibility to trial, site, user, and contact data across your network—helping to bridge data gaps, secure more trial opportunities, hit more targets, and win more awards.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Our platform bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems.

Let us show you in more detail what Better Data, Better Decisions, and Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Devana Solutions CEO Barry Lake on Note to File Podcast

Devana Solutions CEO Barry Lake recently sat down with Brad Hightower of the Note to File Podcast to discuss the current state of the industry and the importance of sites tracking their own metrics using clinical trial software like Devana Solutions.

Offering holistic trial analysis and a dynamic site and investigator database, Devana Solution’s enterprise software gives businesses the crucial support and data management they need to focus on their own business efforts and core competencies. We understand the unique challenges of the clinical trials industry and offer comprehensive solutions such as automated data evaluation and communication, freeing teams from repetitive tasks so they can focus on winning more study contracts.

For life-saving therapies and vaccines to reach patients more quickly, leading research organizations turn to Devana Solutions for cutting-edge cloud-based SaaS technology and services in the clinical trial industry.

Check out Barry’s episode of the Note to File Podcast here.

Note to File Podcast

Note to File is a podcast for clinical research sites, featuring interviews, best practices, and candid commentary from host Brad Hightower, founder of Hightower Clinical and clinical research professional. The podcast was born with the hope of providing a resource for research professionals to share their stories and serve as a source for practical advice for the clinical research community.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Devana Solutions Welcomes Michael Bonavilla as Executive Director, Strategic Partnerships

Michael-BonavillaDevana Solutions is pleased to welcome Michael Bonavilla to our transformative cloud-SaaS company as Executive Director, Strategic Partnerships.

Michael comes to Devana Solutions after working with Bio-Optronics since 2007, where he helped launch the Clinical Conductor Clinical Trial Management System (CTMS). Over the last 15 years, including since 2021 when Bio-Optronics was acquired by Advarra, Michael helped expand the system to over 450 research organization clients to help streamline their business. Michael’s focus is working with clinical research sites of all types across the industry – identifying which technology solutions best fit their unique needs.

“I’ve had the pleasure to be part of the overall maturity of the clinical trial management solution market and have helped introduce many new solutions over the years,” says Michael. “I look forward to the opportunity to work with Devana Solutions and bridging the gap to now offer these same organizations a solution that compliments the CTMS and fills the critical need for business development, trial startup automation, metrics capture, and connectivity activity for the clinical research industry.”

As Executive Director, Strategic Partnerships, Michael will play a vital and highly visible role in Devana Solution’s outreach, education, and sales process. He will use his ample experience in the clinical trials and research industry to consult, educate, and ‘connect the dots’ between Devana’s solution and the needs of our prospective customers.

“Michael is someone I have long respected in the industry, and I was thrilled when he reached out about joining Devana,” explains Devana Solutions CEO Barry Lake. “If you had asked me to pick the top clinical trials technology business development professionals, Michael Bonavilla was at the top of my list.”

Devana Solutions is excited to have Michael join our growing team. With this latest addition, our company is more focused than ever and in the best position to serve our valued partner-clients.

Devana Solutions Welcomes Alex Schneider as Head of Product

Alex SchneiderDevana Solutions is excited to welcome Alex Schneider as Head of Product.

Alex comes to Devana Solutions with over 13 years of experience in user experience research and design, competition intelligence, and product management. Alex joins us from Westat, where he spent over five years, most recently as Head of UX.

Alex has spent his career architecting and delivering innovative, intuitive solutions to hundreds of thousands of researchers, participants, and people across the globe. A staunch advocate for users of all kinds, he works with executives and clients to understand and translate problems and needs into actionable, efficient and effective experiences.

As Head of Product, Alex is responsible for determining product strategy, development, execution, and implementation. He will help define Devana Solution’s product roadmap to deliver world-class experiences by driving innovation through data analysis and qualitative customer feedback.

“Alex epitomizes the expertise the Head of Product for a high-growth SaaS solutions provider like Devana Solutions requires going forward. As the point person from product strategy to go-to-market, there are few more qualified than Alex Schneider. He will be a great compliment to our outstanding leadership team,” says Devana Solutions CEO & Co-founder Barry Lake.

Devana Solutions is thrilled to have Alex join our team – we know he’ll help us do great things!

Improve Study Outcomes with Clinical Trial Software for CROs

The relationship between sponsors and contract research organizations (CROs) is strengthening as outsourcing becomes a clinical trial norm. It is important for the CRO to have a good working relationship with sites in order to ensure that the trial is successful, particularly in the study startup phase, as clinical trials are increasingly expensive and time-consuming endeavors.

Key factors that influence a good relationship and where clinical trial software can help are:

  • Targeted Site Selection
  • Digitized Feasibility
  • Enhanced Site Collaboration and Communication
  • Process and Performance Transparency

Targeted Site Selection

More complex protocols require more precise site selection. Devana’s PROPEL technology allows for CROs to perform automated queries during site selection to determine the right sites or investigators based on the requirements of the protocol. PROPEL allows CROs to store the site and investigator performance and capabilities data that can be managed and updated by the sites, in real-time, allowing for more accurate site selection. Sponsors can be confident that the sites selected by the CRO will be capable of meeting performance expectations, resulting in better study outcomes.

Digitized Feasibility

While feasibility questionnaires are certainly a critical piece to selecting the right sites for a trial, the entire process, as it is today, is a bit archaic. Devana is revolutionizing the feasibility process by allowing CROs to submit a digitized feasibility to the sites selected for each trial. Say goodbye to outdated PDFs and third-party websites. This digital feasibility will pre-populate information that typically remains the same, trial to trial, such as the site’s location and contact information, but allows for the CROs to receive new, trial-specific data such as subject population criteria. The sites can review their previously submitted data for accuracy and respond to any new inquiries, resulting in a speedier feasibility process and a lower cost for the Sponsor.

Enhanced Site Collaboration and Communication

In addition to improving the feasibility process, Devana took it a step further by creating a threaded communication feed between the sites and CROs within the PROPEL platform. If a Sponsor reaches out to a CRO about a trial in bid-defense, needing to quickly know the potential subject pool for a particular indication, the CRO can instantly push out a mass communication to the sites and gather their responses within the platform. No more cumbersome calls or emails to track. Just the same, if a CRO submits a site for a trial, the site can review the details and provide feedback to the CRO or ask questions related to the protocol. It’s a win-win for all involved, the site, the CRO and the Sponsor, since this connectivity allows for more efficient communication throughout the entire clinical trial process.

Process and Performance Transparency

Another important aspect of a good working relationship between Sponsors and CROs is process and performance transparency. The entire clinical trial process, from study startup through close-out, produces a lot of key data. By using PROPEL, CROs have real-time views into the trial, by site, to know exactly where the trial is at any given time. The ability to quickly obtain this data and provide to Sponsors is critical to the swift and successful execution of a trial and the ability to mitigate risk.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Boost Study Contract Wins in the Clinical Trial Industry

Is your clinical trial organization looking to boost study contract wins and shorten the sales cycle? Then you need to ensure you have the right tools in your tech stack. In the age of technology, there are many options available but one you must include is a trial startup software that synchronizes your communication and data for increased efficiency.

A quality trial startup technology solutions provider, like Devana Solutions, will understand the unique challenges of the industry and offer comprehensive solutions such as automated data evaluation and communication that frees the sales team from repetitive tasks so they can focus on winning the study contract.

Devana Solutions Saves Time and Shortens Sales Cycles

By eliminating repetitive tasks, Devana Solutions’ PROPEL platform is able to shorten the overall sales cycle. Put an end to the tedious work in spreadsheets or disparate systems, as PROPEL is able to automate sales processes, capture a complex chain of emails, and account for customized variations.

In addition, PROPEL allows for each cross-functional team to seamlessly communicate with one another and understand what stage the trial is in during the startup process. The best software will be easily accessible to every decision-maker across the trial management process.

How Trial Software Software Boosts Sales in the Clinical Trial Industry

Increased data means more informed decision-making. With a vibrant and dynamic site and investigator database, as well as up to date performance metrics, the sales team is able to focus their efforts to determine the best trial opportunities for their organization. Increased data streams allow the organization to predict how their business development strategies will affect their overall operations.

Choosing the Best Trial Startup Software for Your Clinical Trial Business

The best clinical trial software will be one that is designed with the unique challenges of the clinical trials industry in mind. Offering holistic trial analysis and a dynamic site and investigator database, Devana Solutions’ PROPEL enterprise software gives businesses the crucial support they need to focus their business efforts for much success.

Sign up for a free demo and learn what makes PROPEL the best in the industry.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

2022 World Vaccine Congress: What to Expect

Devana Solutions executives are attending the 2022 World Vaccine Congress in Washington D.C., on April 18-21, 2022. Here’s what leaders in the biopharma industry can expect.The World Vaccine Congress, in existence for over two decades, has grown to become the largest and most established conference dedicated to vaccines, globally. The World Vaccine Congress 2022 will bring together thousands of industry experts across the entire vaccine landscape, with key sessions dedicated to the fight against COVID-19. Taking place April 18-21 at the flagship hotel, Marriott Marquis Washington, DC, the event will be one of the first opportunities to meet in person since the pandemic began to learn, share experiences and ground-breaking knowledge, and network with others who are working against COVID-19 and on other important vaccines.

“If there is anything that the last two years have taught this industry, it’s that the pandemic has certainly put the focus on the need for cutting-edge research to produce more and better vaccines,” Devana Solutions CEO and Co-Founder Barry Lake.

Inside Peek: 2022 World Vaccine Congress Washington

An event that prides itself on covering every subject across the entire vaccine value chain, here is what to expect if you are attending:

  • Visionary Presenters
  • Engaging Agenda
  • Networking Breaks
  • Vaccine Excellence Awards

Visionary Presenters

This year’s presenters are disruptors and visionary industry leaders from the biopharma industry. They are selected for their relevance, dynamism, and insight. Just a handful of speakers at the World Vaccine Congress include:

Engaging Agenda

From basic research to commercial manufacture, World Vaccine Congress covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or new to it because of the pandemic, World Vaccine Congress is the most important meeting you will be part of in 2022.

Here are some of the topics discussed each day:

April 18

  • Biodefense and preparedness
  • Maternal immunization
  • Vaccine Technology
  • Antimicrobial resistance
  • Antibodies in treating COVID and infectious diseases
  • HIV

April 19

  • Plenary Sessions
  • Interactive roundtable discussions
  • Evening drinks & ViE Awards Dinner

April 20 & 21

  • COVID, influenza and other respiratory diseases
  • Immune profiling
  • Cancer immunotherapy
  • One health and veterinary vaccines
  • Clinical trials and development
  • Manufacture
  • Safety
  • Market access
  • Supply & logistics
  • Newly infectious and chronic diseases

Networking

Being the first in-person World Vaccine Congress since 2020, networking is an essential part of the conference experience. You can find new opportunities to collaborate or meet other people in your field. With over 30 scheduled networking events, from coffee breaks to luncheons, there is ample opportunity to learn and network with colleagues across the industry.

Vaccine Excellence Awards

On Tuesday, April 19th, the World Vaccine Congress will be hosting the 15th Annual Vaccine Industry Excellence Awards Ceremony & Dinner. The Scientific Advisory Board members will help make the final decision in each category, and the winners will be announced at the dinner.

“Devana Solutions is proud to have supported many of the leading vaccine research site organizations that stepped up in a big way during the COVID pandemic, including hyperCORE International, Benchmark Research, Centricity Research, Javara Research, Velocity Clinical Research and Accel Research Sites. We wanted to be in Washington, D.C. to support many of these clients nominated for well-deserved Vaccine Excellence Awards,” said Lake.

Are you planning on attending the 2022 World Vaccine Congress Washington? We’d love to chat. Devana Solutions’ CEO and Co-founder Barry Lake and Director, Strategic Partnerships, Emily Hardy, will be attending the show in the nation’s capital and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Emily on LinkedIn or use the contact form at the bottom of the page to set something up before the big event!

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

1 2 3